Insurance Coverage: Many major insurance plans no longer cover Incruse Ellipta starting in 2016. Learn More
FDA Approves Trelegy Ellipta For COPD
Roni Shye - October 26, 2017
COPD, also known as chronic obstructive pulmonary disease, is a progressive lung disease that can cause persistent cough, wheezing, shortness of breath, excess mucus production, and frequent upper respiratory infections.
Treatment is often comprised of a variety of medications, and we have a new one to add to the list—Trelegy Ellipta—a once-daily single inhaler.
What is Trelegy Ellipta indicated for?
Trelegy Ellipta is a once-daily combination inhaler indicated for long-term treatment of patients with COPD, including chronic bronchitis and/or emphysema. See More
50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia
Elizabeth Davis - August 12, 2015
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
What Are Ellipta Inhalers, and Are They Better for COPD?
Roni Shye - March 13, 2015
Breo Ellipta (fluticasone furoate and vilanterol), an inhalation powder used for the treatment of COPD, was the first Ellipta inhaler to become available back in 2013. Over the past two years or so, several more Ellipta options have entered the market.
Ellipta medications tend to be a bit more expensive, but some people prefer them to more traditional types of inhalers.
So, what is unique about the Ellipta device?
The Ellipta from GlaxoSmithKline (GSK) is their new platform inhalation device. See More
Dry Powder Inhalers: Which One is Best for You?
Dr. Sharon Orrange - June 17, 2014
Half of patients with asthma or COPD aren’t using their inhalers properly. Inhaler mishandling has dire consequences—but inhalers are getting much better. With new ones hitting the market every month, you need to get to know them.
Does it matter if your inhaler is a Diskus, Turbohaler or Ellipta? These are all dry powder inhalers (DPIs) and they all use a dry powder formulation of an active drug. They are different than the classic metered dose inhalers like Proventil HFA or Proair HFA. See More
Incruse Ellipta: New COPD Treatment Approved
Roni Shye - May 08, 2014
Incruse Ellipta is a newly approved inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
It was approved by the FDA on April 30, 2014, and will be available by the end of 2014 according to the manufacturer.
What is COPD?
COPD is a disease of the lungs which makes it difficult to breathe. See More
